Form 4: Cushman & Wakefield Director McLean Reports Share Transactions
SEC Form 4
Director Jodie W. McLean reports acquisition and disposal of Cushman & Wakefield plc ordinary shares and restricted stock units.
Summary
- On May 16, 2025, Director Jodie W. McLean converted 15,451 restricted stock units (RSUs) into an equal number of ordinary shares of Cushman & Wakefield plc at a price of $0.
- Following this transaction, McLean directly owns 71,823 ordinary shares.
- On May 15, 2025, McLean was granted 17,013 RSUs, which will vest and settle on May 15, 2026, subject to continued board service.
- The RSUs convert into ordinary shares without any payment.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing director share transactions, which is neutral in sentiment.
Future Outlook
The granted RSUs are subject to continued board service through the vesting date of May 15, 2026.
Industry Context
This filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors. It's typical for directors to receive and convert stock-based compensation.
Comparison to Industry Standards
- Director compensation packages often include restricted stock units that vest over time, aligning director interests with long-term shareholder value.
- The vesting schedules and terms of these RSUs are generally consistent with industry practices for director compensation at publicly traded companies like Cushman & Wakefield.
- Similar companies such as CBRE Group and JLL also utilize equity-based compensation for their directors.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding director compensation and ownership.
- The vesting of RSUs incentivizes the director to contribute to the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | RSUs were granted and vested and settled on this date. |
| 05/15/2025 | RSUs granted to McLean, vesting on May 15, 2026. |
| 05/16/2025 | Conversion of 15,451 RSUs into ordinary shares. |
| 05/19/2025 | Date of signature by attorney-in-fact. |
| 05/15/2026 | Vesting date for RSUs granted on May 15, 2025. |
Keywords
Cushman & Wakefield, Director, Share Transactions, Restricted Stock Units, Ordinary Shares, Form 4, CWK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.